LSC Recent Webinars on BIO
-
Nanoforming Biologics, GLP-1s: From I.V. To Sub Q And Inhaled Delivery
9/9/2025
Developing new delivery routes is essential for creating more effective treatments. Nanoforming enables new routes to simplify dosing, enhance patient comfort, and reduce healthcare costs.
-
Benefits Of Outsourcing To An Integrated CDMO
9/8/2025
Streamlining ADC development through an integrated CDMO can reduce risk and improve quality. Discover why specialized expertise in linker chemistry and bioconjugation is key to overcoming the complexity of ADC manufacturing.
-
Cell Cycle Mapping In Tumors With Advanced Technologies
9/2/2025
Discover how spatial profiling and advanced imaging tools are transforming drug discovery, featuring Wayne Stallaert’s lab’s work on cell cycle mapping and biomarker insights in cancer research.
-
Building Quality By Design For Multi-Specific Therapeutic Proteins
9/2/2025
Platforms incorporating high throughput in silico screening, in vitro expression, and immunosafety of multi-specific molecules can help mitigate potential developability risks and accelerate timelines.
-
Scaling Plasmid DNA Production: A Proven Strategy For Higher Yields
8/27/2025
Learn how an agile manufacturing partner scaled their plasmid DNA production and achieved higher yields by optimizing their media selection and fermentation processes.
-
N-1 Perfusion Strategies For Commercial-Ready Biologics
8/27/2025
Learn how an approach with modular N-1 perfusion strategies shortens seed train timelines and reduces facility strain — enabling upstream processes that scale efficiently and reliably for commercial manufacturing.
-
Unlock Viral Vector Yield And Efficiency With Upstream Intensification
8/26/2025
Streamline viral vector manufacturing with perfusion technologies that reduce costs and improve scalability. Discover how a tangential flow depth filtration system enhances yield and quality.
-
Next-Gen Disease Models And Cell Therapeutics: Innovations In AI, Omics And Collaboration
8/20/2025
Learn how to leverage AI, omics integration, and collaborative research to build more physiologically relevant disease models and accelerate the development of next-gen cell therapies.
-
Efficient Scale-Up Of Monoclonal Antibody Production: From Bench Top To 500L
8/11/2025
Scaling monoclonal antibody production from the lab to a commercial scale can be challenging. Learn about an approach that helps you maintain consistent productivity and product quality across all scales.
-
Process Intensification: Your Guide To "Doing More With Less"
8/5/2025
Explore innovative strategies in process intensification to boost mAb production and hear from industry experts as they share solutions for scaling efficiency and navigating regulatory challenges.